Home＞ACADEMIA
Positioning of Abraxane and Anti-PD-1 Antibodies Will Be Focus of Interest in Revised Guidelines for Gastric Cancer(Mar.23.2016)
The Japanese Gastric Cancer Association (JGCA) is revising the guidelines for the treatment of gastric cancer. Evidence from a number of clinical trials to be announced going forward is expected to be reflected in the revised guidelines’ recommendations on chemotherapy. It plans to announce the revised guidelines in 2017, which would be the third year since their last revision ...
(LOG IN FOR FULL STORY)
-
- Research Group Builds New Pathogenic Variants Database for Japanese Hereditary Breast Cancer Oct.16
-
I/O Pioneers Win Nobel Prize in Medicine; Honjo Prods Japan Firms to Make More Academic Investment at Home
Oct.02
-
New Treatment GL for Statin Intolerance Compiled by Atherosclerosis Society, 3 Other Academic Societies
Oct.01
-
Opdivo Holds Promise as New Option for Malignant Pleural Mesothelioma: Pulmonary Specialist
Sep.21
-
Oncologist Hails Tagrisso Approval for 1st-Line Lung Cancer Treatment
Sep.14
- Prescribers Asked to Stop New Enbrel Biosimilar Use as Maker Can’t Keep Up with Demand(Oct.19)
- Council Approves MHLW’s Plan to Deal with Difficult-to-Develop Drugs and Indications(Oct.19)
- PMDA to Focus on Proper Use of Sakigake and Conditional Approval Systems in Its 4th Midterm Plan(Oct.19)
- Takeda Earns Japan Clearance for Shire Acquisition(Oct.19)
- Council OKs Public Knowledge-Based Applications for Add’l Pediatric Indications for Blopress(Oct.19)
